Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor, Adult: Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01310868
What this trial is testing

Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma

Who this might be right for
Glioblastoma
University College, London 59
Testing effectiveness (Phase 2)Study completedNCT01740258
What this trial is testing

Bevacizumab Beyond Progression (BBP)

Who this might be right for
Malignant GliomaGrade 4 Malignant GliomaGlioblastoma+1 more
Duke University 68
Testing effectiveness (Phase 2)Study completedNCT04743310
What this trial is testing

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Who this might be right for
Central Nervous System Tumor
John Yu 50
Testing effectiveness (Phase 2)Ended earlyNCT02942264
What this trial is testing

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

Who this might be right for
Brain TumorAstrocytomaAstroglioma+2 more
National Cancer Institute (NCI) 53
Early research (Phase 1)Ended earlyNCT00003567
What this trial is testing

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00004892
What this trial is testing

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00032097
What this trial is testing

Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003478
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT00085540
What this trial is testing

FR901228 in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00019058
What this trial is testing

Radiation Therapy in Treating Patients With Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)Looking for participantsNCT05271240
What this trial is testing

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma, Malignant+4 more
Northwell Health 432
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036972
What this trial is testing

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01051557
What this trial is testing

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Not applicableStudy completedNCT00999622
What this trial is testing

Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma

Who this might be right for
Brain and Central Nervous System TumorsInfection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 104
Early research (Phase 1)Study completedNCT00316849
What this trial is testing

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 56
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)Study completedNCT00003996
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 93
Next Page